Literature DB >> 32213574

Verification Is an Integral Part of Antimicrobial Susceptibility Test Quality Assurance.

Romney M Humphries1,2, Patricia J Simner3.   

Abstract

Keywords:  AST; verification

Mesh：

Substances：

Year:  2020        PMID： 32213574      PMCID： PMC7098751          DOI： 10.1128/JCM.01986-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam.

Authors:  Lauren K Flynt; Michael P Veve; Linoj P Samuel; Robert J Tibbetts
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  The quality of antimicrobial discs from nine manufacturers-EUCAST evaluations in 2014 and 2017.

Authors:  J Åhman; E Matuschek; G Kahlmeter
Journal:  Clin Microbiol Infect       Date:  2018-06-07       Impact factor: 8.067

3.  Retraction for Flynt et al., "Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam".

Authors:  Lauren K Flynt; Michael P Veve; Linoj P Samuel; Robert J Tibbetts
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

4.  Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

Authors:  Patrick N A Harris; Paul A Tambyah; David C Lye; Yin Mo; Tau H Lee; Mesut Yilmaz; Thamer H Alenazi; Yaseen Arabi; Marco Falcone; Matteo Bassetti; Elda Righi; Benjamin A Rogers; Souha Kanj; Hasan Bhally; Jon Iredell; Marc Mendelson; Tom H Boyles; David Looke; Spiros Miyakis; Genevieve Walls; Mohammed Al Khamis; Ahmed Zikri; Amy Crowe; Paul Ingram; Nick Daneman; Paul Griffin; Eugene Athan; Penelope Lorenc; Peter Baker; Leah Roberts; Scott A Beatson; Anton Y Peleg; Tiffany Harris-Brown; David L Paterson
Journal:  JAMA       Date:  2018-09-11       Impact factor: 56.272

5.  Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens.

Authors:  James E Kirby; Thea Brennan-Krohn; Kenneth P Smith
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948
  5 in total
  2 in total

Review 1.  The Practical Problem With Carbapenem Testing and Reporting Accurate Bacterial Susceptibilities.

Authors:  Mark Redell; Glenn S Tillotson
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

2.  Raising the Bar: Improving Antimicrobial Resistance Detection by Clinical Laboratories by Ensuring Use of Current Breakpoints.

Authors:  Patricia J Simner; Carol A Rauch; Isabella W Martin; Kaede V Sullivan; Daniel Rhoads; Robin Rolf; Rosemary She; Rhona J Souers; Christina Wojewoda; Romney M Humphries
Journal:  Open Forum Infect Dis       Date:  2022-02-07       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.